Stephan Brand

Diagnosis of specialized intestinal metaplasia by optical coherence tomography

John M. Poneros, Stephan Brand, Brett E. Bouma et al. · Gastroenterology · 2001 · 276 citations · Full text

Medical Imaging, Abdominal Imaging, Gastroenterology +4

Etrolizumab as induction and maintenance therapy for ulcerative colitis in patients previously treated with tumour necrosis factor inhibitors (HICKORY): a phase 3, randomised, controlled trial

Laurent Peyrin‐Biroulet, Ailsa Hart, Peter Bossuyt et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 89 citations · Full text

Inflammation, Anti-inflammatory, Immunology +7

Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study

Marc Ferrante, Geert D’Haens, Vipul Jairath et al. · The Lancet · 2024 · 76 citations

Moderately-to-severely Active Crohn, Immunology, Gastroenterology +5

Detection of high-grade dysplasia in Barrett's esophagus by spectroscopy measurement of 5-aminolevulinic acid-induced protoporphyrin IX fluorescence

Stephan Brand, Thomas D. Wang, Kevin T. Schomacker et al. · Gastrointestinal Endoscopy · 2002 · 74 citations

High-grade Dysplasia, Esophagus, Biochemistry +9

Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis

Robert Brenig, Oltin T. Pop, Evangelos Triantafyllou et al. · Life Science Alliance · 2019 · 39 citations · Full text